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ABSTRACT  
Currently, research on polymers to be used as gene delivery systems is one of the most important 
directions in both polymer science and biomedicine. In this report, we describe a five-step 
procedure to synthesize a novel polymer-peptide hybrid system for gene transfection. The block 
copolymer based on the biocompatible polymer poly(2-methyl-2-oxazoline) (PMOXA) was 
combined with the biocleavable peptide block poly(aspartic acid) (PASP) and finally modified 
with diethylenetriamine (DET). PMOXA-b-PASP(DET) was produced in high yield and 
characterized by 
1
H-NMR and FT-IR. Our biopolymer complexed plasmid DNA (pDNA) 
efficiently, and highly uniform nanoparticles with a slightly negative zeta potential were 
produced. The polymer-peptide hybrid system was able to efficiently transfect HEK293 and 
HeLa cells with GFP pDNA in vitro. Unlike the commonly used polymer, 25kDa branched 
poly(ethylenimine), our biopolymer had no adverse effects on cell growth and viability. In 
summary, the present work provides valuable information for the design of new polymer-peptide 
hybrid-based gene delivery systems with biocompatible and biodegradable properties. 
 
KEYWORDS 
polymer-peptide hybrid system; transfection; gene delivery; nanoparticles; toxicity; 
biodegradability;  
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INTRODUCTION 
Gene therapy is one of the most rapidly growing areas in nanomedicine research 
1
. In general, 
gene delivery systems are classified into two major groups, i.e., viral and non-viral 
2
. Viral 
vectors, such as retroviruses or adenoviruses, are characterized by high transfection efficacies, 
but their major drawback is the concern about biosafety and cytocompatibility 
3
. Non-viral 
systems, such as lipids or polymers, have gained attention especially because of their lower 
cytotoxicity and easier production 
4
. In particular, polymers have a great potential for gene 
therapy because of their chemical versatility 
5,6
.  
Many groups developed polymers or polymer conjugates with linear, branched, or cyclic 
molecule structure for gene delivery to express exogenous proteins 
3,7–14
. To be translated into a 
protein, pDNA needs to overcome two barriers. Firstly, pDNA has to cross the cell membrane, 
and secondly, it must overcome the nuclear membrane. In the nucleus, pDNA will be transcribed 
into mRNA, and the protein of interest will be expressed.  
Polycations are the major type of non-viral polymeric gene nanocarriers. The most widely used 
transfection polymer is 25 kDa branched poly(ethylenimine) (bPEI) 
15
. However, bPEI as well as 
several other polymers including poly(L-lysine) (PLL), poly(propylenimine) (PPI), and 
poly(2-dimethylamino ethyl methacrylate) (PDMAEMA) have cytotoxic side-effects 
16–18
. 
Therefore, developments are focusing on gene vectors with improved transfection efficiency as 
well as decreased cytotoxicity. Several approaches have already been investigated, e.g. ternary 
complexes consisting of PLL, pDNA, and a functional polymer 
19,20
, single cyclic knot polymer 
structures 
21
, or  highly branched degradable copolymers 
22
. 
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The main objective of the present work was the development of a novel polymer-peptide hybrid 
(PPH) based gene delivery system with minimal cytotoxicity, improved biocompatibility, and 
advantageous physico-chemical characteristics. PPH systems have recently attracted great 
attention because this type of block copolymers combines the excellent safety and 
biocompatibility profiles of both synthetic polymers and natural peptides 
3,7,10,23
. We synthesized 
a block copolymer by ring-opening polymerization of 2-methyl-2-oxazoline and β-benzyl-L-
aspartate N-carboxy anhydride (BLA-NCA), using the synthetic polymer 
poly(2-methyl-2-oxazoline) (PMOXA) and the peptide block poly(aspartic acid) (PASP).  
PMOXA is a hydrophilic polymer with stealth 
24
 and protein-repellent properties 
25
, which is an 
advantage for biomedical application 
26
. In vivo, the circulation half-life is prolonged, and 
immunogenicity of the gene delivery system is reduced 
27
. Recently, Pidhatika et al. 
demonstrated that under physiological conditions, PMOXA is more stable than polyethylene 
glycol (PEG) 
28
. This suggests that PMOXA might be an excellent alternative to PEG. Thus, we 
used PMOXA as biocompatible and protein-repellent backbone of the gene delivery system. To 
the best of our knowledge, our biopolymer is the first PMOXA-based PPH for gene delivery. 
PASP is a biocompatible and biodegradable polypeptide that can be used for further 
functionalization of the co-polymer 
29,30
. In order to deliver nucleic acids with our PPH, the 
peptide block was easily modified with the amine-containing unit, diethylenetriamine (DET). 
Flanking primary and secondary amines allow for electrostatic interactions with the negatively 
charged backbone of nucleic acids 
31
. This is necessary to complex pDNA and to form 
nanoparticles. Transfection efficiency of our tailor-made PPH PMOXA-b-PASP(DET) in 
mammalian cells was assessed using pDNA encoding green fluorescence protein (GFP). In 
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addition, we evaluated the biocompatibility of our PPH in vitro as well as in vivo in a preliminary 
safety study. 
Page 5 of 45
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 6
EXPERIMENTAL SECTION 
Materials 
Agarose and sodium dodecyl sulfate (SDS) were purchased from Bio-Rad Laboratories 
(Cressier, Switzerland), and 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolinium bromide 
(MTT) and 1% ethidium bromide solution were obtained from Carl Roth (Karlsruhe, Germany). 
Opti-MEM and 0.25% trypsin-EDTA were obtained from Invitrogen, Life Technologies (Zug, 
Switzerland). Cell media and all other chemicals were purchased from Sigma (Buchs, 
Switzerland): N-(2-hydroxyethyl)phthalimide (99%), trifluoromethanesulfonic anhydride 
(≥ 99%), triethylamine (≥ 99%), 2-methyl-2-oxazoline (98%), sodium azide (≥ 99.5%), 
hydrazine monohydrate (98%), β-benzyl-L-aspartate (98%), triphosgene (98%), DET (99%), 
calcium hydride (95%), acetonitrile (≥ 99.8%), dichloromethane (≥ 99.8%), ethanol (99.8%), 
N,N-dimethylformamide (≥ 99.8%), and tetrahydrofuran (≥ 99.9%). Triethylamine, 
dichloromethane, 2-methyl-2-oxazoline, and acetonitrile were separated from CaH2, and 
tetrahydrofuran was separated from LiAlH4 by distillation. Other chemicals and solvents were 
used without additional purification.  
Synthesis and Characterization of PMOXA-b-PASP(DET)  
The PPH PMOXA-b-PASP(DET) was synthesized via a five-step procedure (Fig. 1A). A 
1
H-NMR was recorded on a Bruker DPX-400 MHz spectrometer in CDCl3 and D2O and was 
analyzed using MestReNova software. The molecular weight of our PPH was assessed using 
1
H-NMR. Due to poor solubility of our PPH in THF, a reliable determination of the molecular 
weight using gel permeation chromatography (GPC) was not possible. Fourier transform infrared 
spectroscopy (FT-IR) (PerkinElmer Spectrum 100 FT-IR Spectrometer) was used to characterize 
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the presence of specific chemical groups. Polymer samples were measured with 256 scans and 
2 cm
-1
 resolution. The spectra were measured from 400 cm
-1
 to 3000 cm
-1
. 
Phthalimidoethyl Triflate 
N-(2-hydroxyethyl)phthalimide (0.63 g, 3.30 mmol) and trimethylamine (TEA, 0.60 mL, 
4.30 mmol) were first dissolved in 20 mL distilled dichloromethane (DCM) at -20°C. 
Afterwards, trifluoromethanesulfonic anhydride (0.67 mL, 4.0 mmol) was mixed with another 
5 mL distilled DCM and then dropped slowly into the solution under argon. The final solution 
was stirred for 3 h at -20°C under argon atmosphere. After washing with cold saturated NaHCO3 
aqueous solution and brine, the organic phase was dried by water-free MgSO4. After filtration of 
MgSO4, the solvent was evaporated, and the residues were dried in high vacuum for 2 h before 
further use.  
N3-PMOXA-Ph 
The initiator, phthalimidoethyl triflate (0.97 g, 3.0 mmol), was dissolved in 30 mL distilled 
acetonitrile, and then distilled 2-methyl-2-oxazoline (22 mL, 259 mmol) was added. Finally, the 
polymerization medium was heated to 80°C for 24 h under argon. The medium was cooled down 
to room temperature (RT), and a 10-fold excess of NaN3 was added to the medium to quench the 
polymerization and introduce the azide functional group. The medium was stirred for 24 h at RT. 
NaN3 was removed by filtration, and the solvent was evaporated. The final product was purified 
by dialysis against water for 48 h. N3-PMOXA-Ph (20 g) was obtained by freeze-drying as a 
colorless powder. The yield was 91%. 
1
H-NMR (400 MHz, δ, CDCl3): 2.0 ppm (m, O=C-CH3, 
Hb), 3.44-3.54 ppm (m, -CH2-CH2-, Hc), 7.35-7.60 ppm (m, -C6H4, Ha).  
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N3-PMOXA-NH2  
N3-PMOXA-Ph (4.25 g, 0.55 mmol) was dissolved in ethanol (100 mL). Hydrazine 
monohydrate (400 mL) was added, and the solution was stirred overnight under argon at RT. 
After evaporation of the solvent, the polymer was re-dissolved in MeOH and precipitated twice 
in cold diethyl ether. The polymer was then re-dissolved in water and dialyzed against water for 
48 h. N3-PMOXA-NH2 (3.8 g) was obtained by freeze-drying as a colorless powder, the yield 
was 89%. 
1
H-NMR (400 MHz, δ, CDCl3): 1.91 ppm (m, O=C-CH3, Hb), 3.38-3.50 ppm 
(m, -CH2-CH2-, Hc). 
N3-PMOXA-PBLA-NH2 
N3-PMOXA-NH2 (0.90 g, 0.12 mmol) was dissolved in water-free DMF. β-Benzyl L-aspartate 
anhydride (2.9 g, 11.62 mmol) was added, and the reaction medium was continually stirred for 
24 h at RT under argon atmosphere. The reaction medium was precipitated twice in cold diethyl 
ether to get 3 g of a colorless solid. The yield was 79%. 
1
H-NMR (400 MHz, δ, CDCl3): 2.10 
ppm (m, O=C-CH3, Hb), 2.66 ppm (broad, -CH2-C=O, Hd), 3.11 ppm (br, -CH2-C=O, Hd), 3.45 
ppm (m, -CH2-CH2-, Ha), 4.28 ppm (br, CH-NH-, Hc), 5.09 ppm (m, -CH2-C6H5, He), 7.25 ppm 
(m, C6H5-, Hf), 8.87 ppm (br, O=C-NH-, Hg).  
N3-PMOXA-PASP(DET)-NH2 
N3-PMOXA-PBLA-NH2 (0.052 g, 0.0029 mmol) was dissolved in water-free DMF (4 mL), 
then DET (0.75 mL, 6.9 mmol) was added. The reaction was carried out at 40°C under argon for 
36 h. The reaction medium was added to 20 mL acetic acid aqueous solution (10%) and then 
dialyzed against a 0.01 N HCl aqueous solution for 48 h. A slightly yellow colored solid powder 
(50 mg) was obtained after lyophilisation. The yield was 98%. 
1
H-NMR (400 MHz, δ, D2O): 
1.99 ppm (m, O=C-CH3, Hb), 2.83 ppm (m, O=C-NH-CH2, He), 2.90 ppm (br, -CH2-C=O, Hd), 
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3.02 ppm (m, -CH2-NH-CH2-, Hf), 3.13 ppm (br, O=C-CH-NH-, Hc), 3.36 ppm (br, -CH2-NH2, 
Hg), 3.43-3.53 ppm (m, -CH2-CH2-N, Ha). 
Cell Culture 
Human embryonic kidney (HEK293) cells and the human epithelial carcinoma cell line HeLa 
were cultured at 37°C under 5% CO2 and saturated humidity in Dulbecco´s modified Eagle´s 
culture medium high glucose (DMEM) supplemented with 10% fetal calf serum (FCS), 
penicillin (100 units/mL), and streptomycin (100 µg/mL). HEK293 cells stably expressing GFP 
for growth characteristic studies were produced by single-cell sorting and were cultured in 
DMEM containing 10% FCS and 0.5 mg/mL Geneticin® (G418, Invitrogen, Life Technologies). 
Transfection assays were performed using the mammalian expression plasmid pTagGFP-N 
(Evrogen) with a size of 4.7 kb. The pDNA vector is encoding the enhanced GFP and comprises 
the immediate early promotor of cytomegalovirus (CMV).  
pDNA Complexation 
To form polymer-pDNA complexes, PMOXA-b-PASP(DET) or bPEI were mixed with pDNA 
in 100 µL complexation medium in defined nitrogen to phosphate (N/P) ratios and incubated for 
30 min at RT. As complexation medium we tested Opti-MEM (pH 7.4), acetate buffer (pH 5.5), 
and tris-buffered saline (TBS; pH 8.0). The resulting polymer-pDNA complexes were used for 
further experiments. For the N/P ratio calculations, we assumed a mass of 179 g/mol for each 
amine-containing unit of our PPH, 43.1 g/mol for each amine-containing unit of bPEI, and 
330 g/mol for each phosphate-containing unit of the pDNA.  
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Gel Retardation Assay 
Freshly prepared PMOXA-b-PASP(DET)-pDNA complexes with N/P ratios of 0.5 to 300 
were analyzed by gel retardation assay. Samples containing either pDNA only or 
PMOXA-b-PASP(DET) only (mock control) were used as controls. For tracking, a loading 
buffer (15% Ficoll 400 in tris/borate/EDTA buffer [TBE]) containing bromophenol blue (0.1%) 
was added to each sample. All samples were separated on a 0.8% agarose gel containing 
0.05 mg/mL ethidium bromide (EtBr) at 80 V for 45 min using TBE buffer. A gel documentation 
system (GelDoc-It TS2 Imager, UVP, Cambridge, UK) was used to visualize pDNA migration.  
PPH-pDNA-Nanocomplex Characterization  
Morphology 
Particle size and morphology of nanocomplexes were analyzed using transmission electron 
microscopy (TEM). Samples were loaded on a carbon-coated grid and stained negatively with 
2% uranylacetate solution. Excess of uranylacetate was removed, and the samples were dried at 
RT overnight. TEM analysis was performed with a CM-100 electron microscope (Philips, 
Eindhoven, Netherlands). 
Size 
Tunable resistive pulse sensing (TRPS) analysis was performed using the qNano (Izon 
Science, Christchurch, New Zealand). Particle size, size distribution, and concentration of 
PPH-pDNA-nanoparticles at N/P ratios of 100 and 300 were analyzed. The nanoparticles were 
passed through a tunable nanopore with size designation np300. Calibration was performed with 
115.0 nm carboxylated polystyrene nanoparticles. Degree of membrane stretch (46.05 mm) and 
applied voltage (0.70 V) were tuned to optimize the resolution for each preparation.  
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Zeta Potential 
Zeta potential of the polymer-pDNA nanocomplexes (PPH or bPEI) was measured using a 
Delsa Nano C Particle Analyzer (Beckman Coulter, Nyon, Switzerland). Laser wavelength was 
658 nm, and measurement angle was 15°. Samples were measured in D-PBS at RT by 
electrophoretic light scattering. Data were converted using the Smoluchowski equation (Delsa 
Nano V3.73/2.30, Beckman Coulter Inc., Brea, USA).  
Stability 
Stability of PMOXA-b-PASP(DET)-pDNA nanocomplexes was assessed using TEM analysis. 
Freshly prepared nanocomplexes were compared to nanocomplexes stored for two weeks in 
complexation medium at 4°C. Sample preparation was performed as described before. 
GFP pDNA Transfection 
To assess the functionality of our PPH-based system, transfection assays were performed. In a 
24-well plate, 120,000 HEK293 or HeLa cells were seeded and cultured in 1 mL DMEM. Cells 
were allowed to adhere for 24 h. Then, 100 µL of freshly prepared PMOXA-b-PASP(DET)-
pDNA complexes (N/P ratios 0 - 300) was added to each well. Controls (0% transfection) were 
defined as incubation of cells with DMEM and complexation buffer (Opti-MEM) only. 
Additionally, cells were incubated with pDNA alone to assess transfection efficiency without 
any transfection reagent. Autofluorescence of cells was determined by incubation of cells with 
the PPH only. GFP expression was analyzed qualitatively by confocal laser scanning microscopy 
(CLSM) or quantitatively by flow cytometry 48 h after transfection (see below).  
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GFP Expression Analysis 
Confocal Laser Scanning Microscopy 
For qualitative analysis of GFP expression, cells were washed with D-PBS and cultured in 
DMEM without phenol red. Live cell imaging was performed using an Olympus FV-1000 
inverted confocal fluorescence microscope (Olympus Ltd., Tokyo, Japan) and a 10x objective 
(numerical aperture 0.40). Excitation and emission wavelengths were 488 nm and 516 nm, 
respectively. Surface area of GFP-positive cells was assessed using ImageJ 1.46 software 
(National Institutes of Health, USA). 
Flow Cytometry 
For quantitative analysis of GFP expression, cells were washed with cold D-PBS (4°C) and 
detached using 0.25% trypsin/EDTA. After two additional washing steps with D-PBS, cells were 
resuspended in staining buffer containing D-PBS, 1% FCS, 0.05% NaN3, and 2.5 mM EDTA. 
Flow cytometry analysis of 10,000 cells was carried out using a FACS Canto II flow cytometer 
(Becton Dickinson, San Jose, USA). The cells were excited at 488 nm, and doublets were 
excluded. The fluorescence signal of GFP was detected in FL1 (505LP - 530/30). To evaluate the 
transfection efficacies (% of GFP-positive cells), Flow Jo VX software (TreeStar, Ashland, OR) 
was used.  
Cell Viability Assay 
To evaluate the cytotoxic effect of PMOXA-b-PASP(DET) and bPEI, native or in complex 
with pDNA, an MTT assay was performed as described previously 
32
. In brief, HEK293 or HeLa 
cells were incubated for 24 h with different concentrations of the test compounds. Afterwards, 
the cells were incubated with MTT reagent at 37°C and 5% CO2 for 4 h. In order to solubilize the 
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reduced MTT for the readout, the culture medium was discarded and a solution containing 20 µL 
3% (v/v) sodium dodecyl sulfate in water and 100 µL 40 mM hydrochloric acid in isopropanol 
was added. The water insoluble formazan dye crystals were dissolved in the dark for 2 hours at 
RT by shaking. Finally, the optical density at 570 nm was measured using a Spectramax M2 
micro-plate reader (Molecular Devices, Sunnyvale, CA, US). The results are given as relative 
cell viability (RCV) compared to control cells (complexation medium only). Interference 
controls were performed to exclude the influence of PMOXA-b-PASP(DET) on the outcome of 
the assay. 
Analysis of Morphology and Cell Growth 
To assess the influence of PMOXA-b-PASP(DET) or bPEI on cell growth characteristics, 
HEK293 stably expressing GFP were seeded at a density of 10,000 cells/well in a 96-well plate. 
GFP-expressing HEK293 cells were used to improve the visibility of growth difference 
compared to non-treated control cells. Opti-MEM, PMOXA-b-PASP(DET), or bPEI was added 
24 h after seeding. After an additional 48 h, CLSM analysis was performed to assess 
morphological changes and cell growth. GFP-expressing HEK293 cells were analyzed by CLSM 
as described above. For quantitative analysis of growth area of cells, ImageJ 1.46 software was 
used. 
Statistical Analysis 
Statistical analysis of transfection experiments, MTT assays, and safety studies was performed 
by one-way analysis of variance (ANOVA) followed by a Bonferroni post-hoc test using 
OriginPro 9.1 (OriginLab Corporation; Northampton, USA) software. All data represent means 
±SD of at least n=3 independent sets of experiments. 
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Transfection efficiency of our PPH was optimized using a 2
3
 full factorial design of experiment 
(DoE) [Stavex 5.2 software, Aicos Technologies, Basel, Switzerland]. The studied variables 
included: (a) Opti-MEM (pH 7.4) or TBS (pH 8.0) as complexation medium, (b) N/P ratio 20 or 
100, and (c) type of transfection protocol (i.e. direct application of transfection mix onto cells 
versus dilution of transfection mix in DMEM prior to addition).  
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RESULTS AND DISCUSSION 
Synthesis and Characterization of PMOXA-b-PASP(DET) 
The main goal of the present work was to synthesize a novel, biocompatible PPH system for 
gene delivery. Phthalimidoethyl triflate was used as an educt for the chemical synthesis 
(Fig. 1A) 
33
. Ring-opening polymerization of 2-methyl-2-oxazoline was quenched using NaN3. 
According to the 
1
H-NMR calculation, the degree of polymerization index was 90 (Table 1).  
Finally, the azide functional group was connected to PMOXA (Fig. 1A). The appearance of 
chemical shift signals from 7.35 ppm to 7.55 ppm on 
1
H-NMR of N3-PMOXA-Ph proved the 
existence of phthalimide (Fig. 1B), indicating that there was no side reaction occurring between 
this protection group and 2-methyl-2-oxazoline during polymerization. In addition, absorbance at 
2010 nm in the FT-IR proved the successful connection of the azide group on the polymer 
(Fig. 1C) 
34
. The azide function offers the possibility to connect special targeting ligands through 
a click chemistry reaction.  
The phthalimide group can be de-protected in the presence of hydrazine monohydrate to afford 
the primary amine 
35
. The chemical shift at the position of 1.91 ppm and 3.38 ppm in the 
1
H-
NMR spectra of N3-PMOXA-NH2 demonstrated that the PMOXA backbone was kept intact in 
the presence of hydrazine monohydrate during the reaction (Fig. 1D).  
N3-PMOXA-NH2 was used as the macroinitiator to initiate ring-opening polymerization of 
β-benzyl L-aspartate anhydride in DMF solution. The new peaks with chemical shifts of 
2.66 ppm, 3.11 ppm, 4.28 ppm, 5.09 ppm, and 7.25 ppm in the 
1
H-NMR demonstrated the 
successful synthesis of N3-PMOXA-b-PBLA with around 50 repeating units (Fig. 1E). To avoid 
intermolecular aminolysis reaction, N3-PMOXA-b-PBLA was treated with a 2500-fold excess of 
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DET. Disappearance of the benzyl group peaks and appearance of DET on chemical shift 
2.83 ppm, 3.02 ppm, and 3.36 ppm in the 
1
H-NMR spectrum proved the successful modification 
of N3-PMOXA-b-PBLA with high density of DET (Fig. 1F + Table 1). This functionality is 
needed to form a complex with negatively charged pDNA. In conclusion, PMOXA-b-
PASP(DET) was successfully synthesized in high yield using a versatile five-step procedure. The 
different steps could be easily modified to change the physico-chemical characteristics of the 
biopolymer. 
Physico-chemical Characterization of PMOXA-b-PASP(DET) as Gene Delivery System 
Gene delivery systems have to meet a number of criteria for successful expression of proteins. 
These include: (I) efficient nucleic acid packaging, (II) entry into cell by endocytosis, (III) 
endosomal escape, (IV) intracellular DNA/carrier release, and (V) entry into the cell 
nucleus 
17,36,37
. The first step for efficient transfection is complete complexation of pDNA by 
electrostatic interactions. PMOXA-b-PASP(DET) has several protonable amino groups with pKa 
values of 9.1 (secondary amine) and 6.3 (primary amine), resulting in a cationic charge at 
physiological pH (7.4) 
38
. In order to assess the complexation power of the PPH, we performed a 
gel retardation assay analysis (Fig. 2 + Fig. S1). The positive charge of PMOXA-b-PASP(DET) 
compensates the negative charge of the pDNA, resulting in a polymer-pDNA nanocomplex with 
decreased charge. In addition, the PPH forms nanocomplexes with pDNA which are too big to 
migrate in the agarose gel.  
Migration of nanocomplexes in the agarose gel slowed with increasing pDNA complexation 
(Fig. 2 + Fig. S1 A-C). At N/P ratios of 4, we observed complete complexation and thus slowed 
migration of the pDNA in the agarose gel. Notably, this observation was independent of the pH 
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(Fig. S1 A-C). Thus, we conclude that transfection experiments should be performed using an 
N/P ratio of at least 4. PMOXA-b-PASP(DET) stored for a long period (nine months) in 
Opti-MEM (2 mg/mL) showed no ability anymore to complex pDNA (Fig. S1D). Thus, PPH 
solutions were always prepared freshly.  
bPEI generally condenses pDNA completely already at N/P ratios of 1.5 - 2.0 
18
. This difference 
can be explained by the fact that nitrogens in the PMOXA backbone of our PPH are part of 
amide bonds. Therefore, they cannot interact with pDNA by electrostatic interactions. The 
relative number of charged amino groups is lower compared to bPEI which consists only of a 
polycationic polymer. 
TEM analysis of PPH-pDNA complexes formed at different N/P ratios between 0.5 and 300 was 
performed (Fig. 3). At an N/P ratio of 20, PPH-pDNA complexes started to form filamentous and 
ring-like morphologies (Fig. 3A). However, starting at an N/P ratio of 50, the PPH formed 
spherical structures with a diameter below 200 nm (Fig. 3B-D + Fig. S2). Interestingly, 
increasing N/P ratios decreased the size of the resulting PPH-pDNA nanoparticles. After two 
weeks in complexation medium, the PPH-pDNA complexes kept their initial, spherical 
morphology (Fig. S2). It should be noted that TEM analysis is a qualitative method, which 
cannot provide precise information on size distribution. This can be attributed to the fact that 
only a limited number of nanoparticles can be analyzed by TEM. Therefore, we used TRPS as a 
quantitative, precise, and very sensitive method. Mean particle diameter of the nanoparticles 
determined by TRPS was 109.8 nm at an N/P ratio of 100 and 101.2 nm at an N/P ratio of 300, 
confirming the corresponding TEM analysis (Fig. 3E+F). The d90/d10 values of 1.5 (N/P 100) 
and 1.4 (N/P 300) were indicative of a narrow and monodisperse size distribution of both 
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nanoparticle types. Nanoparticles in this size range are considered to be optimal for DNA 
transfection and drug delivery since they can easily undergo endocytosis 
39,40
. 
The zeta potential of the PPH-pDNA nanoparticles increased with increasing N/P ratios, ranging 
from -28.0 ± 1.6 mV (N/P 50) to -11.4 ± 2.0 mV (N/P 100), and -5.4 ± 3.4 mV (N/P 300). With 
increasing amounts of PMOXA-b-PASP(DET), the negative charge of pDNA was compensated 
to a larger degree. The PMOXA block in our PPH might stabilize the nanoparticles by steric 
repulsion overcoming lowered electrostatic repulsion. In contrast, bPEI-pDNA complexes at N/P 
ratios of 50, 100, and 300 showed positive zeta potentials (14.4 ± 2.0 mV, 15.7 ± 3.1 mV, and 
14.8 ± 2.6 mV, respectively). 
The slightly negative zeta potential of our PPH-pDNA nanoparticles is favorable for biomedical 
applications in vitro as well as in vivo. Our results demonstrate that the slightly negative charge 
of our PPH-pDNA nanoparticles does not interfere with in vitro cell transfection. We therefore 
did not use higher N/P ratios since negatively charged nanoparticles are known to be less 
cytotoxic and less prone to activate the immune system 
41
. In addition, it is tempting to speculate 
that in vivo our slightly negative nanoparticles will be characterized by low volume of 
distribution and a long half-life in the circulation. In contrast, in vivo use of cationic 
nanoparticles is not possible due to their unspecific interaction with plasma membranes and their 
resulting rapid sequestration in the lung after intravenous administration 
42
.  
Use of PMOXA-b-PASP(DET) as Gene Delivery System 
Our nanoparticle characterization data suggest that the PPH should be used at N/P ratios above 
20. Therefore, we performed a 2
3
 full factorial DoE to evaluate the effect of N/P ratio, 
complexation medium, and transfection method on transfection efficiency. Our model provided a 
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good fit (R
2
 = 0.9822). The complexation medium and N/P ratio were considered as important. 
The N/P ratio had a significant impact on transfection efficiency (P = 0.0002) followed by the 
complexation medium (P = 0.0145). Interestingly, the transfection method had no statistically 
significant impact on transfection efficiency. 
In the gel retardation assay we did not observe any difference in pDNA complexation of our PPH 
at different pH values (Fig. S1). Since it was recently reported that tris buffer enhances the 
transfection efficiency of polyplex solutions we used TBS for our 2
3
 full factorial DoE 
43
. 
However, we observed that transfection using TBS (pH 8.0) was less efficient compared to 
Opti-MEM with a pH of 7.4. At lower pH, more amine groups of the PPH are protonated 
allowing better complex formation of pDNA and PPH. It is important to note, that a 
physiological pH is favorable in respect to biocompatibility and evaluation of the nanoparticles 
in cell culture or in vivo. In conclusion, the best combination from our DoE model was the use of 
a physiological complexation medium and an N/P ratio of 100. 
For qualitative analysis of GFP expression in HEK293 and HeLa cells we used CLSM 
(Fig. 4A+C). Respective polymer-pDNA complexes were always prepared freshly for each 
experiment to minimize the effect of nucleases. Especially, because we observed a decreased 
amount of nanoparticles after storage for two weeks in complexation medium. As expected, cells 
treated with pDNA alone or cells treated with PMOXA-b-PASP(DET) alone (mock control) did 
not express GFP, while cells transfected with PMOXA-b-PASP(DET)-pDNA complexes showed 
GFP expression (Fig. 4A+C). The number of GFP-positive cells increased with increasing N/P 
ratios (20 - 300). In contrast, HEK293 and HeLa cells transfected with bPEI/pDNA showed the 
highest number of GFP-positive cells at an N/P ratio of 20 (Fig. 4A+C). When the N/P ratios 
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were increased even more, the total number of cells decreased being indicative of cytotoxic 
effects of bPEI (Fig. 4A+C).  
To underline our observation, we performed an image analysis of surface area of GFP-positive 
cells (%) as an indicator for the total number of transfected cells. In fact, the image analysis 
revealed that the surface area of GFP-positive cells decreased for higher bPEI N/P ratios. 
Increasing the N/P ratio from 20 to 50 decreased the surface area of GFP-positive cells 
approximately 40%. There was no indication of PPH-pDNA complex-induced cell toxicity 
despite the use of higher amounts of transfection reagent. The surface area of GFP-positive cells 
increased significantly from N/P ratio 20 to 300 in both human cell lines.  
For an exact quantification of transfection efficiency, we performed a flow cytometry analysis 
using N/P ratios not showing any cellular toxicity in CLSM studies. Neither PPH alone nor 
pDNA alone resulted in transfection of cells (Fig. 4B+D). bPEI (N/P = 20) yielded a transfection 
efficiency of 27.0% ± 2.7% and 11.7% ± 2.1%  using the same amount of pDNA and the same 
transfection method as for the PHH in HEK293 and HeLa cells, respectively. Using PPH-pDNA 
complexes, the percentage of GFP-expressing cells increased significantly with increasing N/P 
ratios (Fig. 4B+D). The highest N/P ratio of PMOXA-b-PASP(DET)/pDNA used in our study 
(N/P = 300) showed a GFP-transfection efficiency of 17.3% ± 2.3% in HEK293 cells and 14.1% 
± 2.4%  in HeLa cells. Thus, our PPH resulted in a GFP expression level comparable to the one 
induced by bPEI (Fig. 4B+D). These results are comparable to findings from other recently 
developed polymer conjugates such as cyclodextrin-cored starlike carriers 
44
 or PPH systems 
based on PLL 
45–47
. However, it should be noted that a comparison of published results is 
difficult. Transfection efficiency depends on various factors such as cell line, pDNA promotor, 
or encoded protein.  
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Cytocompatibility of PMOXA-b-PASP(DET) as Gene Delivery System 
Transfection of cells with cationic reagents is often linked to cytotoxic effects since excessive 
positive charges destabilize the cell membrane. In general, high-molecular weight cationic 
polymers show higher cytotoxicity compared to low-molecular polycations 
48
. This interaction is 
more likely when the polyplex dissociates in vivo and the free polycation interacts with cell 
membranes 
49
. In vivo, accumulation of the compound in specific organs can lead to long-term 
side-effects. Therefore, we used the MTT assay to evaluate cytotoxicity of bPEI and 
PMOXA-b-PASP(DET) in presence (Fig. 5B+D) and more importantly in absence (Fig. 5A+C) 
of pDNA in two human cell lines.  
bPEI resulted in strong cytotoxic effects (Fig. 5). A significant decrease in cell viability of more 
than 90% was detected for 163 µg/mL bPEI (P < 0.001) in both cell lines (Fig. 5A+C). This 
effect was even seen at low concentrations of 5 µg/mL bPEI with RCV of 0.58 ± 0.10 in 
HEK293 and 0.42 ± 0.05 in HeLa cells. Similar results were observed for bPEI-pDNA 
complexes (Fig. 5B+D). With increasing N/P ratios, the cell viability decreased significantly 
compared to control cells up to 96.3% ± 2.4% in HEK293 and 93.1% ± 4.3% in HeLa cells for 
N/P 300. Importantly, also N/P ratios used in transfection experiments (N/P 10 and N/P 20) 
resulted in significantly reduced cell viability. 
In sharp contrast, our PPH resulted in high cell viability at all concentrations in absence and 
presence of pDNA (Fig. 5). In both cell lines no significant difference in cell viability compared 
to control cells was observed. There was no concentration-dependent effect, and even high 
concentrations or high N/P ratios were well tolerated (Fig. 5). Concentrations of 163 µg/mL 
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(corresponding to an N/P ratio of 300 used for the transfection assay) resulted in excellent cell 
viability with a RCV of 0.89 ± 0.07 in HEK293 and 0.89 ± 0.10 in HeLa cells (Fig. 5A+C). Cells 
treated with PPH-pDNA nanoparticles showed superior cytocompatibility compared to bPEI at 
all N/P ratios (Fig. 5B+D).  
Our findings are consistent with other PMOXA-based copolymer studies that also showed high 
cytocompatibility 
32
. The PPH might benefit from the biocompatible features of the PMOXA 
block 
50
. In addition, peptide-based polymer hybrids are biodegradable resulting in improved 
long-term cytocompatibility as also shown by other groups 
51
.  
The results of the MTT assay were confirmed by cell growth analysis (Fig. 6A). Transfection 
reagents are commonly used for pDNA delivery in vitro. However, they may interfere with cell 
replication and cell growth. Fischer et al. reported that polycations, such as bPEI, induce necrotic 
cell reactions 
16
. Thus, we performed a CLSM study to analyze the effect of bPEI and our PPH 
on cell growth and morphology (Fig. 6A + Fig. S3). bPEI had a strong influence on the growth 
characteristics. Cells grew slowly and in clusters. This result was confirmed by analyzing the 
growth area of cells after 48 h. bPEI decreased the growth of cells substantially, leading to a 
reduction of the overgrown area to only 2.0% ± 0.9% at a concentration of 11 µg/mL compared 
to that of control cells (Fig. 6A). Furthermore, bPEI caused characteristic apoptotic features such 
as roundness, detachment, cytoplasmic blebbing, and debris (Fig. S3).  
In sharp contrast, growth of cells cultured in medium containing our PPH was not impaired. 
Even at the highest concentrations of our PPH, the relative growth area of 92.0% ± 5.5% was not 
significantly different to that obtained for the control (Fig. 6A + Fig. S3). The highest 
concentration of 163 µg/mL corresponds to an N/P ratio of 300. We conclude that our PPH (but 
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not the commonly used transfection reagent bPEI) is not cytotoxic nor does it impair cell growth. 
These results are in line with the findings from the transfection experiments (Fig. 4). In addition, 
a pilot study in a vertebrate model, namely the zebrafish embryo model 
52–54
, was performed to 
assess the safety of PPH in vivo. In accordance to OECD guidelines, zebrafish embryos were 
dechorionated before the incubation with test compounds due to the high molecular weight of the 
polymers. Zebrafish embryos incubated with our PPH showed a significantly increased survival 
rate as compared to bPEI (P < 0.001): Concentrations of 27 µg/mL bPEI resulted in 100% 
mortality of zebrafish embryos after incubation for 24 h. In sharp contrast, our PPH (27 µg/mL) 
was much better tolerated and the zebrafish embryos showed a survival rate of 48.9% ± 3.8%. 
These results are consistent with other recently published nanotoxicity studies using the zebrafish 
embryo assay 
55
. Toxicity of bPEI was attributed to its cationic properties. 
In summary, our PPH is characterized by a surprisingly high transfection efficiency despite a 
negative zeta potential and the protein-repellent properties of PMOXA 
56
. Cell membranes have 
a negative surface charge predominantly because of the highly anionic glycosaminoglycans 
(GAGs). Therefore, interactions with the cell membrane are more pronounced if the 
nanocomplex has free positively charged groups leading to increased cell uptake. With this 
respect, the incubation conditions in cell culture do not precisely reflect the in vivo situation. In 
our experiments, cells are exposed during a long time (e.g. 48 hours) to high concentrations of 
nanoparticles. Under these conditions, a forced and unspecific uptake of nanoparticles may 
occur. In vivo, sophisticated targeting strategies will be needed to promote a comparable cellular 
uptake. On the other hand, highly cationic polymers, such as bPEI, may destabilize cellular 
membranes leading to toxic side effects.  
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Thus, the better biocompatibility of our PPH may compensate for reduced transfection 
efficiency. A factor facilitating cell transfection using our PPH might be nanoparticle 
morphology. A small particle size (i.e. 100 nm) and narrow size distribution favors pDNA 
delivery into cells 
57–59
. 
To further increase transfection efficiency using our PPH, the amino functionality of the PPH 
could be varied. This modification might improve the interaction with the cell membrane and/or 
enhance endosomal escape of internalized nanoparticles. A long-term perspective of our platform 
technology is the use for in vivo gene therapy. To this end, nanoparticles have to be modified 
with a targeting ligand to direct them to diseased tissues or organs in the body. Thus, a next 
generation of targeted nanoparticles will be needed to achieve this goal. The azide function of the 
PPH could be used for conjugation of targeting ligands via click chemistry. A possible in vivo 
application might be targeting of hepatocytes via the asialoglycoprotein receptor 
60,36
. 
Therapeutic regimens for genetic diseases such as α1-antitrypsin deficiency 
61
 as well as 
strategies against hepatocellular carcinoma 
62
 might profit significantly from such a targeted gene 
therapy approach.  
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CONCLUSION 
The present paper describes the synthesis of a novel PPH system, namely 
PMOXA-b-PASP(DET), which efficiently complexed pDNA. The PPH formed nanocomplexes 
with different morphologies. At high N/P ratios, highly uniform PPH-pDNA nanoparticles 
(d90/10 = 1.4) with a mean diameter around 100 nm were produced. The zeta potential of the 
resulting nanoparticles was slightly negative. Our PPH system showed excellent 
cytocompatibility. The pDNA transfection ability in HEK293 and HeLa cells was comparable to 
that of bPEI.  
In conclusion, the combination of the biocompatible PMOXA backbone with the biodegradable 
PASP block is a novel and promising PPH system for efficient pDNA delivery without 
significant cytotoxic drawbacks. Additionally, our PPH system offers many possibilities for 
chemical modification. These interesting properties might be beneficial for in vivo applications, 
such as targeted gene delivery. 
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TABLES  
Table 1: Characterization of PMOXA-b-PASP(DET). 
DP
a
: degree of polymerization index; Mn: average molecular weight 
 
 
 
Sample 
1
 H NMR 
DP
a
 Mn 
N3-PMOXAn-NH2 90 7700 
N3-PMOXAn-PASP(DET)m-NH2 90:50 18100 
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FIGURE CAPTIONS  
Figure 1. Synthesis and Characterization of PMOXA-b-PASP(DET). (A) Schematic diagram 
illustrating the synthesis of PMOXA-b-PASP(DET). (1) Triflic anhydride, TEA, DCM, -20
o
C; 
(2) 2-methyl-2-oxazoline, acetonitrile, 80
o
C, NaN3; (3) NH2-NH2
.
H2O, ethanol, r.t.; (4) B-benzyl 
L-aspartate anhydride, DMF, r.t. (5) DMF, DET, 40
o
C. (B) 
1
H-NMR spectrum of N3-PMOXA-
Ph in CDCl3. (C) FT-IR spectrum of N3-PMOXA-Ph. Stretching vibration of C=O (1616 cm
-1
). 
Azide group (2010 cm
-1
). (D) 
1
H-NMR spectrum of N3-PMOXA-NH2 in CDCl3. (E) 
1
H-NMR 
spectrum of N3-PMOXA-b-PBLA in CDCl3. (F) 
1
H-NMR spectrum of 
N3-PMOXA-b-PASP(DET) in D2O. 
 
Figure 2. Gel Retardation Assay. Migration of pDNA (4.7 kb), either native or complexed with 
increasing concentrations of PMOXA-b-PASP(DET). Different N/P ratios are shown. The 
samples were separated by electrophoresis on a 0.8% agarose gel in the presence of ethidium 
bromide. pDNA (lane 1) migrates as two bands, i.e. supercoiled and relaxed circular plasmid. An 
extended version of this figure showing that the complexation of pDNA with 
PMOXA-b-PASP(DET) is pH independent is given in the supporting information (Fig. S1). 
 
Figure 3. Characterization of Nanoparticles with Transmission Electron Microscopy 
(TEM) and Tunable Resistive Pulse Sensing (TRPS). Representative TEM images of 
PPH-pDNA complexes at N/P ratios of 20 (A), 50 (B), 100 (C), and 300 (D). Scale 
bars = 200 nm. Additional images of PPH-pDNA nanoparticles at an N/P ratio of 300 are given 
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in the supporting information (Fig. S2). Size analysis of PPH-pDNA nanoparticles at N/P ratios 
of 100 (E) and 300 (F) using TRPS. 
 
Figure 4. HEK293 and HeLa Cells Transfected with pDNA Encoding for Green 
Fluorescence Protein (GFP). Confocal laser scanning microscopy (CLSM) analysis of 
(A) HEK293 and (C) HeLa cells transfected with 1 µg pDNA complexed with our polymer-
peptide hybrid (PPH) system PMOXA-b-PASP(DET) or with bPEI. Representative images after 
transfection at different N/P ratios are shown. Scale bars = 200 µm. Percentages of GFP-positive 
(B) HEK293 and (D) HeLa cells of the same preparations were quantified using flow cytometry. 
Only N/P ratios, which did not show any cytotoxic effects in the CLSM analysis, were analyzed. 
Values are means ± SD of four independent experiments per setting. Level of significance 
compared to pDNA control and corrected for multiple comparisons: * = P < 0.001. 
 
Figure 5. Cell Viability Assay of HEK293 and HeLa Cells Determined by MTT Assay. 
(A) HEK293 and (C) HeLa cells were incubated with different amounts of our polymer-peptide 
hybrid (PPH) PMOXA-b-PASP(DET) or with bPEI for 24 h. For better comparability with 
transfection experiments, the amounts of PPH needed to complex a hypothetical amount of 
1 µg/mL pDNA were tested. Analysis of cell viability of (B) HEK293 and (D) HeLa cells 
incubated with polymer-pDNA nanocomplexes (PPH or bPEI) at different N/P ratios are shown. 
Values are means ± SD of three independent experiments per setting. Level of significance 
compared to control (complexation medium only) and corrected for multiple comparisons: 
* = P < 0.01, ** = P < 0.001. 
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Figure 6. Cell Growth Analysis. Cell growth analysis of GFP-expressing HEK293 cells 48 h 
after addition of our polymer-peptide hybrid (PPH) PMOXA-b-PASP(DET) or bPEI at different 
concentrations. Mean values of growth region of GFP-positive cells (%) compared to control 
conditions (complexation medium only) are given ± SD (n=4). Level of significance compared to 
control and corrected for multiple comparisons: * = P < 0.001. Representative images are shown 
in the supporting information (Fig. S3). 
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Figures 
 
Figure 1. 
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Figure 2. 
 
 
Figure 3. 
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Figure 4.  
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Figure 5.  
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Figure 6.  
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Complexation of pDNA with PMOXA-b-PASP(DET) under different pH conditions 
(Figure S1), stability test of PPH-pDNA-nanoparticles using TEM analysis (Figure S2), and 
representative images of GFP expressing HEK293 cells 48 h after addition of 
PMOXA-b-PASP(DET) or bPEI at different concentrations (Figure S3) are given in the 
Supporting Information. This material is available free of charge via the Internet at 
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diethylenetriamine; FCS, fetal calf serum; FT-IR, Fourier transform infrared spectroscopy; GFP, 
green fluorescence protein; HEK293 cells, human embryonic kidney cells; N/P, nitrogen to 
phosphate; PASP, poly(aspartic acid); pDNA, plasmid DNA; PEG, polyethylene glycol; 
PMOXA, poly(2-methyl-2-oxazoline); PPH, polymer-peptide-hybrid; RT, room temperature; 
TBE, tris/borate/EDTA buffer; TBS, tris-buffered saline; TEA, trimethylamine; TEM, 
transmission electron microscopy; TRPS, tunable resistive pulse sensing; 
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